PANTHEON
LIVE

Serial Number

99562954

Owner

Pantheon Bio, Inc.

Attorney

RYAN S. HILBERT

Filing Date

Dec 23, 2025

Add to watchlist:

No watchlists yet
View on USPTO

PANTHEON Trademark

Serial Number: 99562954

PANTHEON is a trademark filed by Pantheon Bio, Inc. on December 23, 2025. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently pending registration.

Owner Contact Info

Pantheon Bio, Inc.

333 Oyster Point Blvd Suite A
South San Francisco, CA 94080

Entity Type: 03

Trademark Details

Filing Date

December 23, 2025

Registration Date

Not Registered

Goods & Services

Biotechnology research; Research and development in the pharmaceutical and biotechnology fields; Providing medical and scientific research information in the field of biochemical, therapeutic, and pharmaceutical preparations; Research and development of biological computers for designing, developing, testing and manufacturing therapies for the treatment of immunological diseases, inflammatory diseases, neurological diseases, cancer, and other human diseases, and genetic disorders; Scientific and technological consultation services in the field of designing, developing, testing and manufacturing biochemical, therapeutic, and pharmaceutical preparations; Scientific and technological consultation services in the field of designing, developing, testing and manufacturing therapies for the treatment of immunological diseases, inflammatory diseases, neurological diseases, cancer, and other human diseases, and genetic disorders; Custom development of therapies and pharmaceutical and biopharmaceutical products; Pharmaceutical research for the treatment of immunological diseases, inflammatory diseases, neurological diseases, cancer, and other human diseases, and genetic disorders; Providing medical and scientific research information; Consulting services in the field of genetic science

Gene therapy pharmaceutical preparations; Pharmaceutical preparations for gene therapy for the treatment of genetic diseases or disorders; Biological preparations for the treatment of immunological diseases, inflammatory diseases, neurological diseases, cancer, and other human diseases, and genetic disorders; Pharmaceutical preparations and gene therapy products in the nature of biological preparations for the treatment of immunological diseases, inflammatory diseases, neurological diseases, cancer, and other human diseases, and genetic disorders; Pharmaceutical preparations and gene therapy products in the nature of biological preparations containing genetic materials for the treatment of immunological diseases, inflammatory diseases, neurological diseases, cancer, and other human diseases, and genetic disorders

Filing History

NOTIFICATION OF NON-FINAL ACTION E-MAILED
May 4, 2026 GNRN
NON-FINAL ACTION E-MAILED
May 4, 2026 GNRT
NON-FINAL ACTION WRITTEN
May 4, 2026 CNRT
ASSIGNED TO EXAMINER
Apr 25, 2026 DOCK
APPLICATION FILING RECEIPT MAILED
Dec 23, 2025 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 23, 2025 NWOS
NEW APPLICATION ENTERED
Dec 23, 2025 NWAP